ADIL - Adial Pharmaceuticals

-

$undefined

N/A

(N/A)

Adial Pharmaceuticals NasdaqCM:ADIL Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia.

Location: 4870 Sadler Road, Glen Allen, VA, 23060, United States | Website: https://www.adial.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

3.046M

Cash

2.366M

Avg Qtr Burn

-1.72M

Short % of Float

4.91%

Insider Ownership

1.16%

Institutional Own.

7.27%

Qtr Updated

03/31/25